India's New Trilemma

...Kids, jobs, emigration, notes Ajit Balakrishnan. Illustration: Dominic Xavier/Rediff.com   "Aren't you kids going to have children?" I asked one of my nieces who had come for a one-week......

Covid Vaccine IP: How Big Pharma lobbied against India

Communications between the USTR and the world's most powerful pharmaceutical and trade lobbying groups reveal that many raised concerns about India's push to exempt Covid vaccines from intellectual......

Novartis India bullish on rural sales

Swiss drug major Novartis' Indian arm is upbeat about its rural sales initiative, Arogya Parviar and plans to double its reach in the country over the next few years. "Arogya Parivar that started......

Novartis India FY04 net up 83%

Novartis India Ltd has reported a 83.48 per cent rise in net profit at Rs 113.76 crore (Rs 1,137.6 million) for the fiscal ended March 31, 2004, compared to Rs 62 crore (Rs 620 million) in the......

Budget 2024: Wishlist of the pharma industry

There is a need to incentivise R&D investments, offer corporate tax concessions and establish an effective intellectual property rights regime in order to push the growth of domestic pharmaceutical......

India-EFTA trade pact: How Swiss firms stand to gain

Domestic customers will get access to high-quality Swiss products such as watches, chocolates, biscuits, and clocks at lower prices as India will phase out customs duties under its trade pact with......